Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota

doi:10.3748/wjg.v29.i27.4236

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5438)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

108

WORD

HTML

3324

Figures (1-2)

371

Tables (1-5)

530

Sum=4392

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

229

Download

514

Sum=743

Jul 21, 2023 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 21, 2023; 29(27): 4236-4251
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4236

Table 5 Effects of interventions targeting the gut microbiota on pathogenic factors in the gut-muscle axis in cirrhosis

Intervention	SIBO	Gut dysbiosis	Hyperammonemia	Bacterial translocation	Systemic inflammation
Rifaximin	+	+	+	+	CR
Prebiotic disaccharides	ND	+	+	+	+
Probiotics	+	+	+	+	CR
Fecal transplantation	ND	+	ND	ND	ND

+: A positive effect of this drug on this disorder has been reported; SIBO: Small intestinal bacterial overgrowth; CR: Conflicting results, ND: No data.

Citation: Maslennikov R, Alieva A, Poluektova E, Zharikov Y, Suslov A, Letyagina Y, Vasileva E, Levshina A, Kozlov E, Ivashkin V. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World J Gastroenterol 2023; 29(27): 4236-4251
URL: https://www.wjgnet.com/1007-9327/full/v29/i27/4236.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i27.4236